Gallopamil
From Wikipedia, the free encyclopedia
 |
|
|
Gallopamil
|
|
| Systematic (IUPAC) name | |
| 5-[2-(3,4-Dimethoxyphenyl)ethyl-methylamino]-2-propan-2-yl-2-(3,4,5-trimethoxyphenyl)pentanenitrile | |
| Identifiers | |
| CAS number | |
| ATC code | C08 |
| PubChem | |
| Chemical data | |
| Formula | C28H40N2O5 |
| Mol. mass | 484.62 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Gallopamil (INN) is a calcium channel blocker.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||
